Navigation Links
Caliper Life Sciences Collaborates with University of Miami to Automate Next Generation Sequencing Workflows
Date:2/3/2011

HOPKINTON, Mass., Feb. 3, 2011 /PRNewswire/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP) today announced a collaboration with the John P. Hussman Institute for Human Genomics (HIHG) at the University of Miami. As part of this agreement, HIHG is working with Caliper to develop automated protocols for exome capture and library preparation workflows.  HIHG has been an early access partner for the recently released high sensitivity assay for Caliper's LabChip® GX platform.

"At HIHG, we conduct genetic studies that contribute to the better understanding of inherited genetic diseases and disorders," said John Gilbert, PhD, Professor and Director of the Center for Genome Technology at the HIHG. "With our recent implementation of higher capacity sequencing technologies, and our focus on exome sequencing projects, sample preparation has become a bottleneck. We are actively working with Caliper to automate multiple steps of this process and increase our overall sequencing throughput."

"The research being conducted at HIHG is extraordinary and will significantly expand the molecular understanding of disease," said Kevin Hrusovsky, President and CEO of Caliper Life Sciences. "Caliper is excited to collaborate with the HIHG to enable higher throughput exome sequencing."

Details of this collaboration will be presented at the Advances in Genome Biology and Technology conference taking place from February 2-5 in Marco Island, Florida. For a complete list of presentations taking place at AGBT, please visit http://agbt.org/agenda.html.

About Hussman Institute for Human Genomics at the University of Miami

The John P. Hussman Institute for Human Genomics (HIHG) was established at the University of Miami Miller School of Medicine in January 2007 to discover the genetic influences on human health and apply this knowledge to the practice of medicine through improved diagnostics, treatments, and medications, thus translating the unprecedented scientific advance of the "Human Genome Project" into information that can benefit patients directly. The Institute is committed to collaborative pan-institutional initiatives, ensuring that resources, skills, and ideas forthcoming from novel genetic and genomic approaches will be made available to the entire medical community.

About Caliper Life Sciences

Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit www.caliperLS.com.

Caliper, LabChip, Zephyr and Sciclone are registered trademarks of Caliper Life Sciences, Inc.


'/>"/>
SOURCE Caliper Life Sciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Caliper Life Sciences Launches Microfluidic LabChip® DS Platform for UV/VIS Spectral Analysis of Nucleic Acid and Protein Samples
2. NuGEN and Caliper Partner to Eliminate Next-Gen Sequencing Sample Preparation Bottlenecks
3. Caliper Life Sciences Announces Preliminary Results for the Fourth Quarter and 2010
4. Caliper Life Sciences CEO to Present Keynote Presentation at MipTec European Conference
5. Caliper Life Sciences to Present at UBS 2010 Global Life Sciences Conference
6. Caliper Life Sciences Second Quarter 2010 Financial Results Conference Call Notice
7. Caliper Owners Group Meeting Showcases Critical Role of Biopharma and Academic Researchers for Improving Healthcare and Quality of Life
8. Caliper Life Sciences to Webcast Investor Session of Open House
9. Caliper Life Sciences to Present at Jefferies 2010 Global Life Sciences Conference
10. Caliper Enhances Strategic Focus and Increases Growth Capital with Sale of Product Lines to Biotage
11. Caliper Awarded Additional Task Order for EPA ToxCast Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... 6, 2016 According to a new market ... (Polymer, Glass, Silicon), Application (Genomics, Proteomics, Capillary Electrophoresis, POC, Clinical, Environmental, ... global market is projected to reach USD 8.78 Billion by 2021 ... during the forecast period (2016 to 2021). ... ...
(Date:12/6/2016)... , Dec. 6, 2016  SRI International has ... million from the National Institutes of Health,s National ... Division of AIDS (NIAID-DAIDS) to support the manufacturing ... pre-exposure (PreP) agents. Under the seven-year contract, SRI ... development services for candidate HIV-prevention products that emerge ...
(Date:12/6/2016)... ... 2016 , ... RoviSys, a leading independent provider of comprehensive ... the opening of their new office building today. Located at 480 Green Oaks ... 200 employees focused on providing sales, engineering, and support services to customers in ...
(Date:12/5/2016)... Dec 5, 2016 Research and Markets ... - Technologies, Markets and Companies" to their offering. ... , , ... discovery using various -omics technologies such as proteomics and metabolomics. Molecular ... tests are also based on biomarker. Currently the most ...
Breaking Biology Technology:
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, Inc. ... therapeutics focused on the gut microbiome, today announced ... 25,000,000 shares of its common stock and warrants ... at a price to the public of $1.00 ... Synthetic Biologics from the offering, excluding the proceeds, ...
(Date:6/22/2016)... June 22, 2016  The American College of Medical Genetics ... Executive Magazine as one of the fastest-growing trade shows ... at the Bellagio in Las Vegas . ... percentage of growth in each of the following categories: net ... and number of attendees. The 2015 ACMG Annual Meeting was ...
(Date:6/16/2016)... June 16, 2016 The ... expected to reach USD 1.83 billion by 2024, ... Research, Inc. Technological proliferation and increasing demand in ... expected to drive the market growth. ... The development of advanced multimodal techniques for ...
Breaking Biology News(10 mins):